$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX)

Core Viewpoint - Class Action Attorney Juan Monteverde's firm is investigating Dynavax Technologies Corporation regarding its proposed sale to Sanofi, where shareholders are expected to receive $15.50 per share in cash, raising questions about the fairness of the deal [1]. Group 1: Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1]. - The firm is headquartered in the Empire State Building, New York City, and specializes in class action securities litigation [2]. Group 2: Transaction Details - Dynavax shareholders are expected to receive $15.50 per share in cash as part of the proposed transaction with Sanofi [1]. - The investigation aims to determine whether this offer is fair for the shareholders [1].